132 - Long-Term Efficacy and Safety of Zanubrutinib in Patients with Relapsed/Refractory (R/R) Marginal Zone Lymphoma (MZL): Final Analysis of the Magnolia (BGB-3111-214) Trial

Autor: Opat, Stephen, Tedeschi, Alessandra, Hu, Bei, Linton, Kim M, McKay, Pamela, Chan, Henry, Jin, Jie, Sun, Mingyuan, Sobieraj-Teague, Magdalena, Zinzani, Pier Luigi, Browett, Peter, Ke, Xiaoyan, Portell, Craig A., Thieblemont, Catherine, Ardeshna, Kirit, Bijou, Fontanet, Walker, Patricia, Hawkes, Eliza A., Ho, Shir-Jing, Zhou, Keshu, Liang, Zhiyu, Xu, Jianfeng, Tankersley, Chris, Delarue, Richard, Co, Melannie, Trotman, Judith
Zdroj: In Transplantation and Cellular Therapy February 2023 29(2) Supplement:S105-S106
Databáze: ScienceDirect
Externí odkaz: